Effects of Testosterone and estrogen replacement on memory function

Menopause

Volumn 17, Issue 5, 2010, Pages 983-989

  Möller, Marika C ^a   Bartfai, Aniko B ^a   Rådestad, Angelique Flöter ^b  

^a DANDERYD HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Estrogen; Hormone therapy; Memory function; Menopause; Oophorectomy; Testosterone

Indexed keywords

ESTRADIOL VALERATE; ESTROGEN; TESTOSTERONE; TESTOSTERONE UNDECANOATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HUMAN; MEMORY DISORDER; MIGRAINE; NEUROPSYCHOLOGICAL TEST; OVARIECTOMY; RANDOMIZED CONTROLLED TRIAL; STRUCTURED QUESTIONNAIRE; UNSPECIFIED SIDE EFFECT; VERBAL MEMORY;

ANDROGENS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MEMORY DISORDERS; MEMORY, SHORT-TERM; MENOPAUSE; MIDDLE AGED; OVARIECTOMY; PLACEBOS; TESTOSTERONE;

EID: 77957713554     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181dc2e40     Document Type: Article

References (49)

1. Cherrier MM, Matsumoto AM, Amory JK, et al. The role of aroma-tization in testosterone supplementation: effects on cognition in older men. Neurology 2005;64:290-296.
2. Maki PM. Estrogen effects on the hippocampus and frontal lobes. Int J Fertil Womens Med 2005;50:67-71.
3. Sandstrom NJ, Williams CL. Memory retention is modulated by acute estradiol and progesterone replacement. Behav Neurosci 2001;115: 384-393.
4. Wolley C, McEwen BS. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol 1993;336:293-306.
5. Henderson VW, Sherwin BB. Surgical versus natural menopause: cognitive issues. Menopause 2007;14:572-579.
6. LeBlanc ES, Janowsky J, Chan BKS, Nelson HD. Hormone replacement therapy and cognition. Systematic review and meta-analysis. JAMA 2001; 285:1489-1499.
7. Espeland MA, Rapp SR, Shumaker SA, et al. Women's Health Initiative Memory Study. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291:2959-2968.
8. Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmeno-pausal women. The Women's Health Initiative memory study: a randomized clinical trial. JAMA 2003;289:2651-2662.
9. Rocca WA, Bower JH, Maraganore DM, et al. Increased risk of cognitive impairment or dementia in women who underwent oophorec-tomy before menopause. Neurology 2007;69:1074-1083.
10. Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992;17:485-495.
11. Vermeulen A. Plasma androgens in women. J Reprod Med 1998;43: 725-733.
12. Speroff L, Fritz M. Clinical Gynecologic Endocrinology and Infertility. London, UK: Williams & Wilkins, 2004.
13. Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JL. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sul-fate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 2000;85:2832-2838.
14. Davison SL, Bell R, Donath S, Monalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause and oophorectomy. J Clin Endocrinol Metab 2005;90:3847-3853.
15. Al Azzawi F, Palacios S. Hormonal changes during the menopause. Maturitas 2009;63:135-137.
16. Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, von Mühlen D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab 2000; 85:645-651. (Pubitemid 32273648)
17. Bachmann G, Braunstein G, Burger H, et al. Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril 2002;77:661-665.
18. Mazer NA, Leiblum SR, Rosen RC. The Brief Index of Sexual Functioning for Women (BISF-W): a new scoring algorithm and comparison of normative and surgically menopausal populations. Menopause 2000; 7:350-363.
19. Nathorst-Böös J, von Schoultz B, Carlström K. Elective ovarian removal and estrogen replacement therapy: effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynaecol 1993; 14:283-293.
20. Braunstein GD, Sundwall DA, Katz M, et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women. Arch Intern Med 2005;165: 1582-1589.
21. Buster JE, Kingsberg SA, Aguirre O, et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol 2005;105:944-952.
22. Davis SR, van der Mooren MJ, van Lunsen R, et al. Efficacy and safety of testosterone patch for treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 study. Menopause 2006;13:387-396.
23. Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: a prospective crossover study of sex steroid administration in surgical menopause. Psychosom Med 1985;47:339-351.
24. Shifren JL, Davis SR, Moreau M, et al. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 study. Menopause 2006;13: 770-779.
25. Simon J, Braunstein G, Nachtigall L, et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005;90: 5226-5233.
26. Davis SR, Mc Cloud PI, Strauss BJG, et al. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 1995;21:227-236.
27. Dobs AS, Nguyen T, Pace C, Roberts CP. Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women. J Clin Endocrinol Metab 2002; 87:1509-1516.
28. Flöter A, Nathorst-Böös J, Carlström K, Ohlsson C, Ringertz H, von Schoultz B. Effects of combined estrogen/testosterone therapy on bone and body composition in oophorectomized women. Gynecol Endocrinol 2005;20:155-160.
29. Watts NB, Notelovitz M, Timmons MC. Comparison of oral estrogens and estrogen plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause. Obstet Gynecol 1995;85:529-537.
30. Janowsky JS. Thinking with your gonads: testosterone and cognition. Trends Cogn Sci 2006;10:77-82.
31. Bialek M, Zaremba P, Borowicz KK, Czuczwar SJ. Neuroprotective role of testosterone in the nervous system. Pol J Pharmacol 2004;56: 509-518.
32. Wierman ME, Basson R, Davis SR, et al. Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab 2006;91:3697-3710.
33. Aleman A, Bronk E, Kessel RPC, Koppeschaar HPF, van Honk J. A single administration of testosterone improves visuospatial ability in young women. Psychoneuroendocrinology 2004;29:612-617.
34. Postma A, Meyer G, Tuiten A, van Honk J, Kessels RPC, Thijssen J. Effects of testosterone administration on selective aspects of object-location memory in healthy young women. Psychoneuroendocrinology 2000;25:563-575.
35. Wisniewski AB, Nguyen TT, Dobs AS. Evaluation of high-dose estrogen and high-dose estrogen plus methyltestosterone treatment on cognitive task performance in postmenopausal women. Horm Res 2002;58: 150-155.
36. Schattmann L, Sherwin BB. Testosterone levels and cognitive functioning in women with polycystic ovary syndrome and in healthy young women. Horm Behav 2007;51:587-596.
37. Schattmann L, Sherwin BB. Effects of the pharmacologic manipulation of testosterone on cognitive functioning in women with polycystic ovary syndrome: a randomized, placebo-controlled treatment study. Horm Behav 2007;51:579-586.
38. Shah S, Bell RJ, Savage G, et al. Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial. Menopause 2006;13:600-608.
39. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendo-crinology 1988;13:345-357.
40. Flöter A, Nathorst-Böös J, Carlström K, von Schoultz B. Serum lipids in oophorectomized women during estrogen and testosterone replacement therapy. Maturitas 2004;47:123-129.
41. Flöter A, Nathorst-Böös J, Carlström K, von Schoultz B. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being. Climacteric 2002;5: 357-365.
42. Wechsler D. WAIS-R Manual. New York: The Psychological Corporation, 1981.
43. Wilson B, Cockburn J, Baddeley A. RBMT, The Rivermead Behavioral Memory Test. Svensk Manual. (Transl.). Stockholm, Sweden: Psykolo-giförlaget, 2001.
44. Lezak MD, Howieson DB, Hannay HJ. Neuropsychological Assessment. 4th ed. New York: Oxford University Press, 2004.
45. Södergård R, Bäckström T, Shanbag V, et al. Calculation of free and bound fractions of testosterone and estradiol-17A to plasma proteins at body temperature. J Steroid Biochem Mol Biol 1982;18:801-804.
46. Thilers PP, Macdonald SW, Herlitz A. The association between endogenous free testosterone and cognitive performance: a population-based study in 35 to 90 year-old men and women. Psychoneuroendocrinology 2006;31:565-576.
47. Flöter A, Carlström K, von Schoultz B, Nathorst-Böös J. Administration of testosterone undecanoate in postmenopausal women: effects on androgens, estradiol and gonadotrophins. Menopause 2000;7: 251-256.
48. Sherwin BB, Gelfand MM. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med 1987;49:397-409.
49. Sherwin BB. Estrogen and cognition in women. Endocr Rev 2003;24: 133-151.